March 3, 2025 | Oakland, CA — MedLegalNews.com — The DWC Pharmacy and Therapeutics Committee is now accepting applications from licensed physicians and pharmacists for the 2025–2027 term. The California Division of Workers’ Compensation (DWC) oversees this committee, which plays a crucial role in advising the DWC Administrative Director on updates and improvements to California’s Medical Treatment Utilization Schedule (MTUS) drug formulary.
Serving on the DWC Pharmacy and Therapeutics Committee allows medical professionals to directly influence how medications are reviewed, classified, and approved within the state’s workers’ compensation system. Members contribute clinical expertise that helps ensure injured workers receive appropriate, evidence-based treatments while maintaining cost efficiency and compliance with MTUS guidelines.
Committee Responsibilities and Term Details
The Pharmacy & Therapeutics Committee established under Labor Code section 5307.29, meets quarterly (January, April, July, and October) to review and recommend adjustments to the drug formulary. Members serve a two-year term and provide expert input on medication guidelines for treating injured workers.
Currently, six positions are available:
- Three physician seats (for medical doctors or doctors of osteopathy)
- Three pharmacist seats (for licensed pharmacists)
Existing committee members may reapply for another term. Although service is voluntary, members receive reimbursement for certain travel expenses.
Application Process and Deadline
Physicians and pharmacists interested in applying must submit a completed application package, which includes:
- Application form
- Conflict of interest disclosure form
- Committee regulations outlining qualifications and responsibilities
These documents are available online.
How to Apply
Email applications to: formulary@dir.ca.gov
Deadline: Close of business on Friday, May 16, 2025
For questions, email formulary@dir.ca.gov with the subject line “P&T Application Question”
Why This Matters for Medical and Legal Professionals
The P&T Committee’s recommendations influence prescription drug access and treatment protocols for California’s injured workers. Participation in this committee provides a valuable opportunity for medical professionals to shape evidence-based treatment guidelines in workers’ compensation cases.
Source: California Department of Industrial Relations
For more updates on medical and legal issues affecting healthcare providers, insurers, and attorneys, visit MedLegalNews.com.
🔗 Read More from MedLegalNews.com:
- DWC Opens 15-Day Public Comment Period on Utilization Review Regulations
- San Diego Contractors Ordered to Pay Back Wages After Labor Violations
- California Invests $68 Million to Expand Apprenticeships and Create Jobs
- California Supreme Court Limits Employer Penalties in Prison Attack Case
- New York Doctor Convicted in $24M Medicare Fraud Scheme
FAQs: About the DWC Pharmacy and Therapeutics Committee
What is the DWC Pharmacy and Therapeutics Committee?
The DWC Pharmacy and Therapeutics Committee advises California’s Division of Workers’ Compensation on updates to the Medical Treatment Utilization Schedule (MTUS) drug formulary.
Who can apply to join the DWC Pharmacy and Therapeutics Committee?
Licensed physicians and pharmacists with expertise in workers’ compensation, clinical pharmacology, or occupational medicine are eligible to apply.
How often does the DWC Pharmacy and Therapeutics Committee meet?
The committee meets quarterly—in January, April, July, and October—to review new medications, evidence-based guidelines, and formulary revisions.
Why is joining the DWC Pharmacy and Therapeutics Committee important for medical professionals?
Participation offers a chance to influence California’s drug formulary and ensure that injured workers receive effective, evidence-based treatments.